
美洲国际精细化工及医药原料展览会(CPhI America / Informex USA)是北美最大的最专业的国际精细化工及医药原料展览会,由UBM主办,美国合成有机化学品制造商协会(SOCMA)支持,该展览会是美国目前唯一的精细化工及医药原料专业展览会,从1985年开始在美国费城举行,在国际化工界享有盛誉,尤其是定制合成业务更是该展览会的突出特色。展会主题:可持续化学,融资趋势,页岩气更新,电子化学的进步,特种化学品概述,提高石油采收率,生物燃料文摘,商业化新兴技术,生命科学行业展望。

展会同欧洲展一样,按医药分为:CPhI 医药原料展、ICSE世界临床制药展、P-MEC世界制药机械、包装设备与材料展和InnoPack世界生物制药展,四展合一是全球制药行业不可不去的盛会,特别是北美庞大的市场,吸引着全球制药企业每年参展。

INFORMEX是引领于全球精细与特种化学品行业的年度盛会。 INFORMEX得到了社会各界的聚会场所,其供应商超过30年,并继续成为这个行业内领先者,并举行学习和实现业务发展和创新目标的论坛。INFORMEX吸引负责原料、采购、来料加工、工艺、规模化、工程设计、科研、销售及市场推广等专业观众,以及来自全国各地的精细与特种化学品的最终用途市场,包括更多的超过2500名高管及高层与会者:农用化学品及植保,消费品及家居用品,施工,电子、设备和IT,香精香料,食品与饮料,生命科学与生物技术,油漆和涂料,石油化工与能源,制药,塑料和聚合物,纺织材料。

美国是全球精细与专用化学品生产和消费最发达的国家之一,近几年美国精细化学品年销售额约为上千亿美元,高居世界首位。目前中国企业参加Informex展会的反馈情况看,85%的企业认为观众的专业程度达到或超过预期,78%的企业认为产品在美国非常有市场,67%的本届展商现场预定了下届展位,另外绝大部分展商通过参展达到了开拓市场、收集信息、维护客户关系、品牌推广及销售等目的。金融危机对美国经济的负面影响已逐渐消退,目前正是进入美国市场的大好时机。

展会规模:参展的企业有BASF, Chevron Phillips, Clariant, Solvay, Lonza等400多家企业参展,超过4000名专业观众参观了该展会。其中三分之二的观众来自北美地区,其它来自欧洲、亚洲及其它地区,更有70%观众有采购意向。展商以创新产品或最新产品为主展示,现场丰富的展品、专业的技术、新的生产原料及技术解决方案吸引了众多专业观众前去参观洽谈。

展品范围(Show Products):
定制化学品、医药原料及中间体、胶粘剂和密封剂、农用化学品、食品添加剂、油漆和涂料、染料和颜料、感光材料、催化剂和助剂、化妆品、香精香料、清洁剂、生物技术、电子化学品、添加剂、水处理剂、感光材料、电子化学品、家用化学品、化妆品、香精香料、委托加工、特种及精细化学品等。

展会报告(Show Reports):
The pharmaceutical industry is undergoing a period of unprecedented transformation. From rapid advancements in biologics and cell therapies to the integration of artificial intelligence in drug development, the pace of change has never been more intense. In this dynamic environment, staying ahead to industry trends, creating and maintaining partnerships, and accessing cutting-edge solutions is essential to thrive as part of both the marketplace and the pharma community as a whole.
Launching at Philadelphia’s Pennsylvania Convention Center on June 2, CPHI Americas 2026 is a three-day event which offers the pharmaceutical industry precisely what the moment demands: a premium, content-first experience specifically designed for the contract development and manufacturing ecosystem.
This year’s edition of CPHI Americas represents far more than an incremental improvement over previous years. Moving beyond the traditional trade show format, our upcoming show is driven by a specialized focus on contract manufacturing, ensuring every aspect of programming, networking, and content delivers maximum relevance and business value to the CDMO and CMO community. This evolution comes in direct response to the industry's shifting dynamics; the rise in outsourcing has created an ecosystem where CDMOs, CMOs, biotech innovators, regulatory experts, investors, private equity groups, and technology partners must collaborate more closely than ever before.
CPHI Americas 2026 positions itself at the center of this ecosystem, providing the platform where these critical relationships can be formed, strengthened, and leveraged for mutual success. With over 295 exhibitors, 3,700 attendees, and 80+ industry thought leaders confirmed for this year’s show, you’ll get unparalleled access to the decision-makers, innovators, and experts shaping the future of pharmaceutical manufacturing in the Americas.










